165 related articles for article (PubMed ID: 2268501)
1. Interleukin 6 (IL-6).
Matsuda T; Hirano T
Biotherapy; 1990; 2(4):363-73. PubMed ID: 2268501
[No Abstract] [Full Text] [Related]
2. Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma.
Suematsu S; Hibi M; Sugita T; Saito M; Murakami M; Matsusaka T; Matsuda T; Hirano T; Taga T; Kishimoto T
Curr Top Microbiol Immunol; 1990; 166():13-22. PubMed ID: 2073791
[No Abstract] [Full Text] [Related]
3. Biological and clinical aspects of interleukin 6.
Hirano T; Akira S; Taga T; Kishimoto T
Immunol Today; 1990 Dec; 11(12):443-9. PubMed ID: 2127356
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin-6 and its receptor].
Matsuda T; Hirano T
Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1184-94. PubMed ID: 1908108
[No Abstract] [Full Text] [Related]
5. Interleukin 6 and its receptor in the immune response and hematopoiesis.
Hirano T; Taga T; Matsuda T; Hibi M; Suematsu S; Tang B; Murakami M; Kishimoto T
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():155-66; discussion 166-7. PubMed ID: 2324554
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 in infection and cancer.
Sehgal PB
Proc Soc Exp Biol Med; 1990 Nov; 195(2):183-91. PubMed ID: 2236101
[No Abstract] [Full Text] [Related]
7. [Biology of interleukin-6. Role in lymphoplasmacytic hemopathies].
Levy Y; Brouet JC
Ann Med Interne (Paris); 1992; 143(8):533-43. PubMed ID: 1303597
[No Abstract] [Full Text] [Related]
8. Up-regulation of IL-6-receptors by IL-3 on a plasma cell leukaemia cell line which proliferates dependently on both IL-3 and IL-6.
Kobayashi M; Tanaka J; Imamura M; Maeda S; Iwasaki H; Tanaka M; Tsudu Y; Sakurada K; Miyazaki T
Br J Haematol; 1993 Apr; 83(4):535-8. PubMed ID: 8518172
[TBL] [Abstract][Full Text] [Related]
9. IL-6 as a growth factor for human multiple myeloma cells--a short overview.
Nilsson K; Jernberg H; Pettersson M
Curr Top Microbiol Immunol; 1990; 166():3-12. PubMed ID: 2073810
[No Abstract] [Full Text] [Related]
10. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias.
Hirano T
Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619
[TBL] [Abstract][Full Text] [Related]
11. The evidence for interleukin-6 as an autocrine growth factor in malignancy.
Akira S; Kishimoto T
Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291
[TBL] [Abstract][Full Text] [Related]
12. IL6 and thrombocytopoiesis.
Ishibashi T; Asano S
Res Immunol; 1992 Sep; 143(7):752-4. PubMed ID: 1439150
[No Abstract] [Full Text] [Related]
13. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor.
Vink A; Coulie P; Warnier G; Renauld JC; Stevens M; Donckers D; Van Snick J
J Exp Med; 1990 Sep; 172(3):997-1000. PubMed ID: 2388041
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 6 and plasma cell neoplasias.
Hirano T; Kishimoto T
Prog Growth Factor Res; 1989; 1(3):133-42. PubMed ID: 2491260
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6: historical background, genetics and biological significance.
Wolvekamp MC; Marquet RL
Immunol Lett; 1990; 24(1):1-9. PubMed ID: 2197219
[TBL] [Abstract][Full Text] [Related]
16. [Basic and clinical aspects of IL-6].
Nakajima K; Hirano T
Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6: an overview.
Van Snick J
Annu Rev Immunol; 1990; 8():253-78. PubMed ID: 2188664
[No Abstract] [Full Text] [Related]
18. Interleukin-6: biologic properties and role in lymphoproliferative disorders.
Seymour JF; Kurzrock R
Cancer Treat Res; 1996; 84():167-206. PubMed ID: 8724631
[No Abstract] [Full Text] [Related]
19. [IL-6 and IL-6 receptor].
Murakami M; Hirano T
Seikagaku; 1990 Jan; 62(1):32-5. PubMed ID: 2181039
[No Abstract] [Full Text] [Related]
20. The biology of interleukin-6.
Hirano T
Chem Immunol; 1992; 51():153-80. PubMed ID: 1567541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
